Diffusion Regulation in the Vitreous Humor.

The efficient treatment of many ocular diseases depends on the rapid diffusive distribution of solutes such as drugs or drug delivery vehicles through the vitreous humor. However, this multicomponent hydrogel possesses selective permeability properties, which allow for the diffusion of certain molecules and particles, whereas others are immobilized. In this study, we perform an interspecies comparison showing that the selective permeability properties of the vitreous are conserved across several mammalian species. We identify the polyanionic glycosaminoglycans hyaluronic acid and heparan sulfate as two key macromolecules that establish this selective permeability. We show that electrostatic interactions between the polyanionic macromolecules and diffusing solutes can be weakened by charge screening or enzymatic glycosaminoglycan digestion. Furthermore, molecule penetration into the vitreous is also charge-dependent and only efficient as long as the net charge of the molecule does not exceed a certain threshold.

[1]  U. Rant,et al.  Excessive counterion condensation on immobilized ssDNA in solutions of high ionic strength. , 2003, Biophysical journal.

[2]  K. Ribbeck,et al.  Characterization of particle translocation through mucin hydrogels. , 2010, Biophysical journal.

[3]  S. D. Bustros,et al.  Treatment of cytomegalovirus retinitis with ganciclovir. , 1987, Ophthalmology.

[4]  T. Ciulla,et al.  Novel approaches for retinal drug delivery. , 2002, Ophthalmology clinics of North America.

[5]  P. C. Hiemenz,et al.  Principles of colloid and surface chemistry , 1977 .

[6]  Gerald S. Manning,et al.  Limiting Laws and Counterion Condensation in Polyelectrolyte Solutions I. Colligative Properties , 1969 .

[7]  H. Cohen,et al.  Nanoparticles for gene delivery to retinal pigment epithelial cells. , 2005, Molecular vision.

[8]  B. Khoobehi,et al.  INTRAVITREAL INJECTION OF LIPOSOME‐ENCAPSULATED GANCICLOVIR IN A RABBIT MODEL , 1987, Retina.

[9]  E. Balazs,et al.  Studies on the structure of the vitreous body. VI. Biochemical changes during development. , 1959, The Journal of biological chemistry.

[10]  A. Pirie,et al.  OX VITREOUS HUMOUR. 1.—THE RESIDUAL PROTEIN* , 1948, The British journal of ophthalmology.

[11]  Clive G. Wilson,et al.  Topical and systemic drug delivery to the posterior segments. , 2005, Advanced drug delivery reviews.

[12]  Justin Hanes,et al.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.

[13]  G. S. Manning.  Limiting laws and counterion condensation in polyelectrolyte solutions. IV. The approach to the limit and the extraordinary stability of the charge fraction. , 1977, Biophysical chemistry.

[14]  Elias Fattal,et al.  Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery , 2000, Progress in Retinal and Eye Research.

[15]  A. Eller,et al.  Regulation of eye size by the retinal basement membrane and vitreous body. , 2006, Investigative ophthalmology & visual science.

[16]  Robert Gurny,et al.  Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. , 2003, Investigative ophthalmology & visual science.

[17]  D. Meisner,et al.  Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine , 1989 .

[18]  H. Qian,et al.  Single particle tracking. Analysis of diffusion and flow in two-dimensional systems. , 1991, Biophysical journal.

[19]  P. McDonnell,et al.  Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[20]  D. Heinegård,et al.  The large chondroitin sulphate proteoglycan versican in mammalian vitreous. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[21]  D. Aggarwal,et al.  Vesicular systems in ocular drug delivery: an overview. , 2004, International journal of pharmaceutics.

[22]  Sridhar Duvvuri,et al.  Drug delivery to the retina: challenges and opportunities , 2003, Expert opinion on biological therapy.

[23]  P. Bishop.  Structural macromolecules and supramolecular organisation of the vitreous gel , 2000, Progress in Retinal and Eye Research.

[24]  N. Shelke,et al.  Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases , 2011, Drug Delivery and Translational Research.

[25]  Samuel K. Lai,et al.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses , 2009, Proceedings of the National Academy of Sciences.

[26]  Jonathan Howse,et al.  Importance of particle tracking and calculating the mean-squared displacement in distinguishing nanopropulsion from other processes. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[27]  E. Sackmann,et al.  Digital imaging processing for biophysical applications , 2004 .

[28]  W. Freeman,et al.  Cytomegalovirus retinitis and response to therapy with ganciclovir. , 1987, Ophthalmology.

[29]  J. Engbersen,et al.  Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy. , 2013, Nanomedicine.

[30]  M. Litt,et al.  Rheology of the vitreous body: part 3. Concentration of electrolytes, collagen and hyaluronic acid. , 1994, Biorheology.

[31]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[32]  Elizabeth Nance,et al.  A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue , 2012, Science Translational Medicine.

[33]  John E. Scott.  The chemical morphology of the vitreous , 1992, Eye.

[34]  Yen Cu,et al.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. , 2009, Molecular pharmaceutics.

[35]  E. Balazs,et al.  Age-related changes in the vitreus and lens of rhesus monkeys (Macaca mulatta). , 1980, Experimental eye research.

[36]  R. Baumgärtel,et al.  Ion-specific effects modulate the diffusive mobility of colloids in an extracellular matrix gel. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[37]  J. Cunha-Vaz.  The blood-retinal barriers , 1976, Documenta Ophthalmologica.

[38]  Oliver Lieleg,et al.  Selective filtering of particles by the extracellular matrix: an electrostatic bandpass. , 2009, Biophysical journal.

[39]  P. Couvreur,et al.  Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis , 2004, European journal of immunology.

[40]  K. Csaky,et al.  Investigating the Movement of Intravitreal Human Serum Albumin Nanoparticles in the Vitreous and Retina , 2009, Pharmaceutical Research.

[41]  H. Flynn,et al.  Pharmacokinetics of intravitreal antibiotics in endophthalmitis , 2014, Journal of Ophthalmic Inflammation and Infection.

[42]  M. Refojo,et al.  Biodegradable microspheres for vitreoretinal drug delivery. , 2001, Advanced drug delivery reviews.

[43]  U. Chakravarthy,et al.  Quantitative analysis of hyaluronan in vitreous humor using capillary electrophoresis , 1994, Electrophoresis.

[44]  K. Braeckmans,et al.  Vitreous: a barrier to nonviral ocular gene therapy. , 2005, Investigative ophthalmology & visual science.

[45]  P. Bishop.  The biochemical structure of mammalian vitreous , 1996, Eye.

[46]  A. Mitra,et al.  Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. , 2001, Experimental eye research.

[47]  F. J. Romero,et al.  Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients , 1992, Documenta Ophthalmologica.

[48]  K. Ribbeck,et al.  Biological hydrogels as selective diffusion barriers. , 2011, Trends in cell biology.

[49]  P. Couvreur,et al.  Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms. , 1998, Journal of drug targeting.